🔎 Trials Near Me

Akèy › Dyabèt Tip 2 › Kansas › Wichita

Etid klinik pou Dyabèt Tip 2 nan Wichita, KS

10 etid pou Dyabèt Tip 2 ap chèche patisipan nan sit nan ak bò kote Wichita (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Ap rekriteFaz 3
  • Alliance for Multispecialty Research LLC, Wichita
  • Alliance for Multispecialty Research Newton, Newton · 24 mi lwen
Laj 18 a 99 · Tout sèks · Mizajou Oct 5, 2026 · NCT07684144

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

Ap rekriteFaz 3
  • Alliance for Multispecialty Research, Newton · 24 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07817251

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Ap rekriteFaz 3
  • Tekton Research - Wichita, Wichita
  • AMR El Dorado, El Dorado · 27 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Ap rekriteFaz 3
  • Research Site, Newton · 24 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07784270

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Ap rekriteFaz 2
  • Alliance for Multispecialty Research - Wichita East, Wichita
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07296484

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus

Ap rekriteFaz 3
  • Research Site, Newton · 24 mi lwen
  • Research Site, El Dorado · 27 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT07662044

A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies

Ap rekriteEtid obsèvasyon
  • Research Site, El Dorado · 27 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT07606066

HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

Ap rekriteFaz 2
  • AMR Clinical - El Dorado, El Dorado · 27 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Apr 23, 2026 · NCT07546929

Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus

Ap rekriteFaz 2
  • AMR Clinical - Newton, Newton · 24 mi lwen
  • AMR Clinical, El Dorado, El Dorado · 27 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Mar 18, 2026 · NCT07282743

Etid Dyabèt Tip 2 nan lòt vil

Lòt etid nan Wichita

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.